India’s primary market is gearing up for an action-packed week, with five companies collectively targeting close to Rs 14,500 crore through public offerings that open over the next few days. The lineup spans consumer brands, healthcare networks and one of the country’s biggest asset managers, setting the stage for a heavy inflow of retail and institutional bids.
Wakefit Solutions Kicks Off Offerings On Monday
Direct-to-consumer sleep and home solutions brand Wakefit Solutions will launch its Rs 1,288.89 crore IPO on Monday, December 8, closing on December 10.
The issue comprises a fresh share sale of Rs 377.18 crore and an OFS of Rs 911.71 crore.
The company has set a price range of Rs 185–Rs 195 per share. Retail investors can apply for one lot of 76 shares, requiring a minimum outlay of Rs 14,820. At the upper limit, Wakefit is eyeing a post-issue valuation of around Rs 6,400 crore.
Corona Remedies’ All-OFS Issue Also Opens Monday
Pharmaceutical player Corona Remedies will open its Rs 655.37 crore IPO on December 8, closing on December 10 as well. The offer is entirely OFS, meaning the company will not receive fresh capital.
The IPO is priced between Rs 1,008 and Rs 1,062 per share, with 35 per cent reserved for retail applicants. A minimum bid of 14 shares translates to an entry amount of Rs 14,868. The company is seeking a valuation of nearly Rs 6,495 crore at the top end of the range.
Nephrocare Health Services Opens Mid-Week
Kidney-care provider Nephrocare Health Services will open its Rs 971.05 crore IPO on Wednesday, December 10, closing on December 12. The offer includes a fresh issue worth Rs 353.41 crore and an OFS of Rs 517.64 crore.
The price band stands at Rs 438–Rs 460. Retail investors can subscribe with a lot size of 35 shares, requiring Rs 14,720. Nephrocare is targeting a post-issue market cap of Rs 4,615 crore.
Park Medi World Targets Rs 920 Cr
Hospital chain Park Medi World will also hit the market on December 10, running until December 12. Its Rs 920 crore IPO comprises a Rs 770 crore fresh issue and a Rs 150 crore OFS.
Shares will be priced between Rs 154 and Rs 162, with retail buyers allowed to bid for 92-share lots at a minimum cost of Rs 14,904. The healthcare operator aims for a valuation approaching Rs 7,000 crore at peak pricing.
ICICI Prudential AMC Launches One Of 2025’s Biggest Issues
The headliner of the week arrives Friday, as ICICI Prudential AMC opens a Rs 10,602 crore IPO on December 12, closing on December 16. The offering is a full OFS, with ICICI Bank offloading part of its stake.
Shares are priced between Rs 2,061 and Rs 2,165. Retail investors can enter with a six-share lot, costing Rs 12,990. The company has also set aside nearly 25 lakh shares for ICICI Bank shareholders. At the upper price limit, the AMC is eyeing a market capitalization close to Rs 1.1 lakh crore, making it the fourth-largest IPO of 2025. |
